請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/70570
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 陳小梨(Show-Li Chen) | |
dc.contributor.author | Yun-Hsin Huang | en |
dc.contributor.author | 黃韻心 | zh_TW |
dc.date.accessioned | 2021-06-17T04:31:22Z | - |
dc.date.available | 2020-09-04 | |
dc.date.copyright | 2018-09-04 | |
dc.date.issued | 2018 | |
dc.date.submitted | 2018-08-10 | |
dc.identifier.citation | Apel, E.D., Roberds, S.L., Campbell, K.P., and Merlie, J.P. (1995). Rapsyn may function as a link between the acetylcholine receptor and the agrin-binding dystrophin-associated glycoprotein complex. Neuron 15, 115-126.
Balice-Gordon, R.J. (1997). Age-related changes in neuromuscular innervation. Muscle Nerve Suppl 5, S83-87. Barrett, E.F., Barrett, J.N., and David, G. (2011). Mitochondria in motor nerve terminals: function in health and in mutant superoxide dismutase 1 mouse models of familial ALS. J Bioenerg Biomembr 43, 581-586. Bartoli, M., Ramarao, M.K., and Cohen, J.B. (2001). Interactions of the rapsyn RING-H2 domain with dystroglycan. J Biol Chem 276, 24911-24917. Belluardo, N., Westerblad, H., Mudó, G., Casabona, A., Bruton, J., Caniglia, G., Pastoris, O., Grassi, F., and Ibáñez, C.F. (2001). Neuromuscular junction disassembly and muscle fatigue in mice lacking neurotrophin-4. Mol Cell Neurosci 18, 56-67. Bensimon, G., Lacomblez, L., and Meininger, V. (1994). A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med 330, 585-591. Bevan, S., and Steinbach, J.H. (1977). The distribution of alpha-bungarotoxin binding sites of mammalian skeletal muscle developing in vivo. J Physiol 267, 195-213. Biferi, M.G., Cohen-Tannoudji, M., Cappelletto, A., Giroux, B., Roda, M., Astord, S., Marais, T., Bos, C., Voit, T., Ferry, A., et al. (2017). A New AAV10-U7-Mediated Gene Therapy Prolongs Survival and Restores Function in an ALS Mouse Model. Mol Ther 25, 2038-2052. Bloch, R.J., and Hall, Z.W. (1983). Cytoskeletal components of the vertebrate neuromuscular junction: vinculin, alpha-actinin, and filamin. J Cell Biol 97, 217-223. Bähler, M., and A., R. (2002). Calmodulin signaling via the IQ motif. FEBS Lett 513, 107-113. Boillée, S., and Cleveland, D.W. (2004). Gene therapy for ALS delivers. Trends Neurosci 27, 235-238. Brüning, J.C., Michael, M.D., Winnay, J.N., Hayashi, T., Hörsch, D., Accili, D., Goodyear, L.J., and Kahn, C.R. (1998). A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2, 559-569. Braithwaite, A.W., and Harris, A.J. (1979). Neural influence on acetylcholine receptor clusters in embryonic development of skeletal muscles. Nature 279, 549-551. Calabria, E., Ciciliot, S., Moretti, I., Garcia, M., Picard, A., Dyar, K.A., Pallafacchina, G., Tothova, J., Schiaffino, S., and Murgia, M. (2009). NFAT isoforms control activity-dependent muscle fiber type specification. Proc Natl Acad Sci U S A 106, 13335-13340. Campanari, M.L., García-Ayllón, M.S., Ciura, S., Sáez-Valero, J., and Kabashi, E. (2016). Neuromuscular Junction Impairment in Amyotrophic Lateral Sclerosis: Reassessing the Role of Acetylcholinesterase. Front Mol Neurosci 9, 160. Cary, G.A., and La Spada, A.R. (2008). Androgen receptor function in motor neuron survival and degeneration. Phys Med Rehabil Clin N Am 19, 479-494. Chang, S.W., Tsao, Y.P., Lin, C.Y., and Chen, S.L. (2011). NRIP, a novel calmodulin binding protein, activates calcineurin to dephosphorylate human papillomavirus E2 protein. J Virol 85, 6750-6763. Chen, C.Y., Tsai, M.S., Lin, C.Y., Yu, I.S., Chen, Y.T., Lin, S.R., Juan, L.W., Chen, Y.T., Hsu, H.M., Lee, L.J., et al. (2012). Rescue of the genetically engineered Cul4b mutant mouse as a potential model for human X-linked mental retardation. Hum Mol Genet 12, 4270-4285. Chen, H.H., Chen, W.P., Yan, W.L., Huang, Y.C., Chang, S.W., Fu, W.M., Su, M.J., Yu, I.S., Tsai, T.C., Yan, Y.T., et al. (2015). NRIP is newly identified as a Z-disc protein, activating calmodulin signaling for skeletal muscle contraction and regeneration. J Cell Sci 128, 4196-4209. Chen, H.H., Fan, P., Chang, S.W., Tsao, Y.P., Huang, H.P., and Chen, S.L. (2017). NRIP/DCAF6 stabilizes the androgen receptor protein by displacing DDB2 from the CUL4A-DDB1 E3 ligase complex in prostate cancer. Oncotarget 8, 21501-21515. Chen, H.H., Tsai, L.K., Liao, K.Y., Wu, T.C., Huang, Y.H., Huang, Y.C., Chang, S.W., Wang, P., Y,, Tsao, Y.P., and Chen, S.L. (2018). Muscle-restricted nuclear receptor interaction protein knockout causes motor neuron degeneration through down-regulation of myogenin at the neuromuscular junction. J Cachexia Sarcopenia Muscle. Chen, P.H., Tsao, Y.P., Wang, C.C., and Chen, S.L. (2008). Nuclear receptor interaction protein, a coactivator of androgen receptors (AR), is regulated by AR and Sp1 to feed forward and activate its own gene expression through AR protein stability. Nucleic Acids Res 36, 51-66. Chen, P.J., Martinez-Pena Y Valenzuela, I., Aittaleb, M., and Akaaboune, M. (2016). AChRs Are Essential for the Targeting of Rapsyn to the Postsynaptic Membrane of NMJs in Living Mice. J Neurosci 36, 5680-5685. Cheng, A., Morsch, M., Murata, Y., Ghazanfari, N., Reddel, S.W., and Phillips, W.D. (2013). Sequence of age-associated changes to the mouse neuromuscular junction and the protective effects of voluntary exercise. PLoS One 8, e67970. Cheung, C.L., Chan, B.Y., Chan, V., Ikegawa, S., Kou, I., Ngai, H., Smith, D., Luk, K.D., Huang, Q.Y., Mori, S., et al. (2009). Pre-B-cell leukemia homeobox 1 (PBX1) shows functional and possible genetic association with bone mineral density variation. Hum Mol Genet 18, 679-687. Chin, E.R., Olson, E.N., Richardson, J.A., Yang, Q., Humphries, C., Shelton, J.M., Wu, H., Zhu, W., Bassel-Duby, R., and Williams, R.S. (1998). A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev 12, 2499-2509. Chou, H.J., Lai, D.M., Huang, C.W., McLennan, I.S., Wang, H.D., and Wang, P.Y. (2013). BMP4 is a peripherally-derived factor for motor neurons and attenuates glutamate-induced excitotoxicity in vitro. PLoS One 8, e58441. Cohen, S.A., and Fischbach, G.D. (1977). Clusters of acetylcholine receptors located at identified nerve-muscle synapses in vitro. Dev Biol 59, 24-38. DeChiara, T.M., Bowen, D.C., Valenzuela, D.M., Simmons, M.V., Poueymirou, W.T., Thomas, S., Kinetz, E., Compton, D.L., Rojas, E., Park, J.S., et al. (1996). The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell 85, 501-512. Del Campo, A., Jaimovich, E., and Tevy, M.F. (2016). Mitochondria in the Aging Muscles of Flies and Mice: New Perspectives for Old Characters. Oxid Med Cell Longev 2016, 9057593. Delbono, O. (2003). Neural control of aging skeletal muscle. Aging Cell 2, 21-29. Deschenes, M.R. (2011). Motor unit and neuromuscular junction remodeling with aging. Curr Aging Sci 4, 209-220. Deschenes, M.R., Roby, M.A., Eason, M.K., and Harris, M.B. (2010). Remodeling of the neuromuscular junction precedes sarcopenia related alterations in myofibers. Exp Gerontol 45, 389-393. Dion, P.A., Daoud, H., and Rouleau, G.A. (2009). Genetics of motor neuron disorders: new insights into pathogenic mechanisms. Nat Rev Genet 10, 769-782. Dobbins, G.C., Luo, S., Yang, Z., Xiong, W.C., and Mei, L. (2008). alpha-Actinin interacts with rapsyn in agrin-stimulated AChR clustering. Mol Brain 1, 18. Dobrowolny, G., Aucello, M., Rizzuto, E., Beccafico, S., Mammucari, C., Boncompagni, S., Belia, S., Wannenes, F., Nicoletti, C., Del Prete, Z., et al. (2008). Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab 8, 425-436. Dobrowolny, G., Giacinti, C., Pelosi, L., Nicoletti, C., Winn, N., Barberi, L., Molinaro, M., Rosenthal, N., and Musarò, A. (2005). Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. J Cell Biol 168, 193-199. Dupuis, L., and Loeffler, J.P. (2009). Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models. Curr Opin Pharmacol 9, 461-466. Ehret, G.B., O'Connor, A.A., Weder, A., Cooper, R.S., and Chakravarti, A. (2009). Follow-up of a major linkage peak on chromosome 1 reveals suggestive QTLs associated with essential hypertension: GenNet study. Eur J Hum Genet 17, 1650-1657. Fambrough, D.M., Drachman, D.B., and Satyamurti, S. (1973). Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors. Science 182, 293-295. Farrar, M.A., and Kiernan, M.C. (2015). The Genetics of Spinal Muscular Atrophy: Progress and Challenges. Neurotherapeutics 12, 290-302. Ferraro, E., Molinari, F., and Berghella, L. (2012). Molecular control of neuromuscular junction development. J Cachexia Sarcopenia Muscle 3, 13-23. Finsterer, J., Papić, L., and Auer-Grumbach, M. (2011). Motor neuron, nerve, and neuromuscular junction disease. Curr Opin Neurol 24, 469-474. Fischer, L.R., Culver, D.G., Tennant, P., Davis, A.A., Wang, M., Castellano-Sanchez, A., Khan, J., Polak, M.A., and Glass, J.D. (2004). Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol 185, 232-240. Friese, A., Kaltschmidt, J.A., Ladle, D.R., Sigrist, M., Jessell, T.M., and Arber, S. (2009). Gamma and alpha motor neurons distinguished by expression of transcription factor Err3. Proc Natl Acad Sci U S A 106, 13588-13593. Funakoshi, H., Belluardo, N., Arenas, E., Yamamoto, Y., Casabona, A., Persson, H., and Ibáñez, C.F. (1995). Muscle-derived neurotrophin-4 as an activity-dependent trophic signal for adult motor neurons. Science 268, 1495-1499. Gautam, M., Noakes, P.G., Mudd, J., Nichol, M., Chu, G.C., Sanes, J.R., and Merlie, J.P. (1995). Failure of postsynaptic specialization to develop at neuromuscular junctions of rapsyn-deficient mice. Nature 377, 232-236. Ghazanfari, N., Linsao, E.L., Trajanovska, S., Morsch, M., Gregorevic, P., Liang, S.X., Reddel, S.W., and Phillips, W.D. (2015). Forced expression of muscle specific kinase slows postsynaptic acetylcholine receptor loss in a mouse model of MuSK myasthenia gravis. Physiol Rep 3. Gilhus, N.E., and Verschuuren, J.J. (2015). Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol 14, 1023-1036. Gonzalez-Freire, M., de Cabo, R., Studenski, S.A., and Ferrucci, L. (2014). The Neuromuscular Junction: Aging at the Crossroad between Nerves and Muscle. Front Aging Neurosci 6, 208. Gurney, M.E., Pu, H., Chiu, A.Y., Dal Canto, M.C., Polchow, C.Y., Alexander, D.D., Caliendo, J., Hentati, A., Kwon, Y.W., and Deng, H.X., et al. (1994). Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264, 1772-1775. Hartzell, H.C., and Fambrough, D.M. (1973). Acetycholine receptor production and incorporation into membranes of developing muscle fibers. Dev Biol 30, 153-165. Higuchi, O., Hamuro, J., Motomura, M., and Yamanashi, Y. (2011). Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis. Ann Neurol 69, 418-422. Hoch, W., McConville, J., Helms, S., Newsom-Davis, J., Melms, A., and Vincent, A. (2001). Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 7, 365-368. Huijbers, M.G., Niks, E.H., Klooster, R., de Visser, M., Kuks, J.B., Veldink, J.H., Klarenbeek, P., Van Damme, P., de Baets, M.H., van der Maarel, S.M., et al. (2016). Myasthenia gravis with muscle specific kinase antibodies mimicking amyotrophic lateral sclerosis. Neuromuscul Disord 26, 350-353. Inoue, A., Setoguchi, K., Matsubara, Y., Okada, K., Sato, N., Iwakura, Y., Higuchi, O., and Yamanashi, Y. (2009). Dok-7 activates the muscle receptor kinase MuSK and shapes synapse formation. Sci Signal 2, ra7. Johnson, M.L., Robinson, M.M., and Nair, K.S. (2013). Skeletal muscle aging and the mitochondrion. Trends Endocrinol Metab 24, 247-256. Kanning, K.C., Kaplan, A., and Henderson, C.E. (2010). Motor neuron diversity in development and disease. Annu Rev Neurosci 33, 409-440. Kim, N., Stiegler, A.L., Cameron, T.O., Hallock, P.T., Gomez, A.M., Huang, J.H., Hubbard, S.R., Dustin, M.L., and Burden, S.J. (2008). Lrp4 is a receptor for Agrin and forms a complex with MuSK. Cell 135, 334-342. Lamboley, C.R., Murphy, R.M., McKenna, M.J., and Lamb, G.D. (2013). Endogenous and maximal sarcoplasmic reticulum calcium content and calsequestrin expression in type I and type II human skeletal muscle fibres. J Physiol 591, 6053-6068. Li, L., Xiong, W.C., and Mei, L. (2018). Neuromuscular Junction Formation, Aging, and Disorders. Annu Rev Physiol 80, 159-188. Li, W., Brakefield, D., Pan, Y., Hunter, D., Myckatyn, T.M., and Parsadanian, A. (2007). Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS. Exp Neurol 203, 457-471. Liewluck, T., and Saperstein, D.S. (2015). Progressive Muscular Atrophy. Neurol Clin 33, 761-773. Lin, H., Hu, H., Duan, W., Liu, Y., Tan, G., Li, Z., Liu, Y., Deng, B., Song, X., Wang, W., et al. (2018). Intramuscular Delivery of scAAV9-hIGF1 Prolongs Survival in the hSOD1G93A ALS Mouse Model via Upregulation of D-Amino Acid Oxidase. Mol Neurobiol 55, 682-695. Lin, W., Burgess, R.W., Dominguez, B., Pfaff, S.L., Sanes, J.R., and Lee, K.F. (2001). Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse. Nature 410, 1057-1064. Lino, M.M., Schneider, C., and Caroni, P. (2002). Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J Neurosci 22, 4825-4832. Maselli, R.A., Wollman, R.L., Leung, C., Distad, B., Palombi, S., Richman, D.P., Salazar-Grueso, E.F., and Roos, R.P. (1993). Neuromuscular transmission in amyotrophic lateral sclerosis. Muscle Nerve 16, 1193-1203. Misawa, H., Hara, M., Tanabe, S., Niikura, M., Moriwaki, Y., and Okuda, T. (2012). Osteopontin is an alpha motor neuron marker in the mouse spinal cord. J Neurosci Res 90, 732-742. Mishra, V.N., Kalita, J., Kesari, A., Mitta, B., Shankar, S.K., and Misra, U.K. (2004). A clinical and genetic study of spinal muscular atrophy. Electromyogr Clin Neurophysiol 44, 307-312. Mitsui, T., Kawajiri, M., Kunishige, M., Endo, T., Akaike, M., Aki, K., and Matsumoto, T. (2000). Functional association between nicotinic acetylcholine receptor and sarcomeric proteins via actin and desmin filaments. J Cell Biochem 77, 584-595. Miyoshi, S., Tezuka, T., Arimura, S., Tomono, T., Okada, T., and Yamanashi, Y. (2017). DOK7 gene therapy enhances motor activity and life span in ALS model mice. EMBO Mol Med 9, 880-889. Murray, L.M., Talbot, K., and Gillingwater, T.H. (2010). Review: neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy. Neuropathol Appl Neurobiol 36, 133-156. Nakano, K., Miki, Y., Hata, S., Ebata, A., Takagi, K., McNamara, K.M., Sakurai, M., Masuda, M., Hirakawa, H., Ishida, T., et al. (2013). Identification of androgen-responsive microRNAs and androgen-related genes in breast cancer. Anticancer Res 33, 4811-4819. Ohno, K., Ohkawara, B., and Ito, M. (2017). Agrin-LRP4-MuSK signaling as a therapeutic target for myasthenia gravis and other neuromuscular disorders. Expert Opin Ther Targets 21, 949-958. Pérez-García, M.J., and Burden, S.J. (2012). Increasing MuSK activity delays denervation and improves motor function in ALS mice. Cell Rep 2, 497-502. Park, K.H., Franciosi, S., and Leavitt, B.R. (2013). Postnatal muscle modification by myogenic factors modulates neuropathology and survival in an ALS mouse model. Nat Commun 4, 2906. Pasinelli, P., and Brown, R.H. (2006). Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci 7, 710-723. Payne, A.M., Zheng, Z., Messi, M.L., Milligan, C.E., González, E., and Delbono, O. (2006). Motor neurone targeting of IGF-1 prevents specific force decline in ageing mouse muscle. J Physiol 570, 283-294. Phillips, W.D., Kopta, C., Blount, P., Gardner, P.D., Steinbach, J.H., and Merlie, J.P. (1991). ACh receptor-rich membrane domains organized in fibroblasts by recombinant 43-kildalton protein. Science 251, 568-570. Picard, M., Hepple, R.T., and Burelle, Y. (2012). Mitochondrial functional specialization in glycolytic and oxidative muscle fibers: tailoring the organelle for optimal function. Am J Physiol Cell Physiol 302, C629-641. Pramatarova, A., Laganière, J., Roussel, J., Brisebois, K., and Rouleau, G.A. (2001). Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J Neurosci 21, 3369-3374. Ramarao, M.K., Bianchetta, M.J., Lanken, J., and Cohen, J.B. (2001). Role of rapsyn tetratricopeptide repeat and coiled-coil domains in self-association and nicotinic acetylcholine receptor clustering. J Biol Chem 276, 7475-7483. Reist, N.E., Werle, M.J., and McMahan, U.J. (1992). Agrin released by motor neurons induces the aggregation of acetylcholine receptors at neuromuscular junctions. Neuron 8, 865-868. Renton, A.E., Chiò, A., and Traynor, B.J. (2014). State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci 17, 17-23. Ross, J.M. (2011). Visualization of mitochondrial respiratory function using cytochrome c oxidase/succinate dehydrogenase (COX/SDH) double-labeling histochemistry. J Vis Exp, e3266. Rothstein, J.D. (2009). Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol 65, S3-9. Sanes, J.R., and Lichtman, J.W. (2001). Induction, assembly, maturation and maintenance of a postsynaptic apparatus. Nat Rev Neurosci 2, 791-805. Schaeffer, L., de Kerchove d'Exaerde, A., and Changeux, J.P. (2001). Targeting transcription to the neuromuscular synapse. Neuron 31, 15-22. Schymick, J.C., Talbot, K., and Traynor, B.J. (2007). Genetics of sporadic amyotrophic lateral sclerosis. Hum Mol Genet 16, R233-242. Seijffers, R., Zhang, J., Matthews, J.C., Chen, A., Tamrazian, E., Babaniyi, O., Selig, M., Hynynen, M., Woolf, C.J., and Brown, R.H.J. (2014). ATF3 expression improves motor function in the ALS mouse model by promoting motor neuron survival and retaining muscle innervation. Proc Natl Acad Sci U S A 111, 1622-1627. Shi, Y., Li, Z., Xu, Q., Wang, T., Li, T., Shen, J., and Zhang, F. (2011). Common variants on 8p12 and 1q24.2 confer risk of schizophrenia. Nat Genet 43. Simon, N.G., Huynh, W., Vucic, S., Talbot, K., and Kiernan, M.C. (2015). Motor neuron disease: current management and future prospects. Intern Med J 45, 1005-1013. Sullivan, K.A., Kim, B., and Feldman, E.L. (2008). Insulin-like growth factors in the peripheral nervous system. Endocrinology 149, 5963-5971. Sun, S., Ling, S.C., Qiu, J., Albuquerque, C.P., Zhou, Y., Tokunaga, S., Li, H., Qiu, H., Bui, A., Yeo, G.W., et al. (2015). ALS-causative mutations in FUS/TLS confer gain and loss of function by altered association with SMN and U1-snRNP. Nat Commun 6, 6171. Taylor, J.P., Brown, R.H.J., and Cleveland, D.W. (2016). Decoding ALS: from genes to mechanism. Nature 539, 197-206. Tsai, T.C., Lee, Y.L., Hsiao, W.H., Tsao, Y.P., and Chen, S.L. (2005). NRIP, a novel nuclear receptor interaction protein, enhances the transcriptional activity of nuclear receptors. J Biol Chem 280, 20000-20009. Tse, N., Morsch, M., Ghazanfari, N., Cole, L., Visvanathan, A., Leamey, C., and Phillips, W.D. (2014). The neuromuscular junction: measuring synapse size, fragmentation and changes in synaptic protein density using confocal fluorescence microscopy. J Vis Exp. Tsujihata, M., Hazama, R., Yoshimura, T., Satoh, A., Mori, M., and Nagataki, S. (1984). The motor end-plate fine structure and ultrastructural localization of acetylcholine receptors in amyotrophic lateral sclerosis. Muscle Nerve 7, 243-249. Valdez, G., Tapia, J.C., Kang, H., Clemenson, G.D.J., Gage, F.H., Lichtman, J.W., and Sanes, J.R. (2010). Attenuation of age-related changes in mouse neuromuscular synapses by caloric restriction and exercise. Proc Natl Acad Sci U S A 107, 14863-14868. Willadt, S., Nash, M., and Slater, C. (2018). Age-related changes in the structure and function of mammalian neuromuscular junctions. Ann N Y Acad Sci 1412, 41-53. Yang, X., Arber, S., William, C., Li, L., Tanabe, Y., Jessell, T.M., Birchmeier, C., and Burden, S.J. (2001). Patterning of muscle acetylcholine receptor gene expression in the absence of motor innervation. Neuron 30, 399-410. Zhang, Y., Ye, J., Chen, D., Zhao, X., Xiao, X., Tai, S., Yang, W., and Zhu, D. (2006). Differential expression profiling between the relative normal and dystrophic muscle tissues from the same LGMD patient. J Transl Med 4. Ziskind-Conhaim, L., and Bennett, J.I. (1982). The effects of electrical inactivity and denervation on the distribution of acetylcholine receptors in developing rat muscle. Dev Biol 90, 185-197. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/70570 | - |
dc.description.abstract | 核受體交互作用蛋白(Nuclear receptor interaction protein, NRIP)是一個鈣離子依賴性的攜鈣素(calmodulin)結合蛋白。NRIP可以透過調節粒線體的活性與鈣離子的平衡來調控肌肉的收縮功能。在本實驗室先前的研究中,發現全身性NRIP基因剔除小鼠有肌肉失養和運動能力顯著受損的情形。另外,我們在肌肉NRIP基因剔除小鼠中證明了肌肉NRIP的缺失會導致運動神經元 (α-motor neuron)退化和神經肌肉接合處(neuromuscular junction, NMJ)的異常。此外,我們也發現NRIP和乙醯膽鹼受體(acetylcholine receptors, AChRs)共定位(co-localize)於神經肌肉接合處,並且NRIP作為一個營養因子,能藉由穩定神經肌肉接合處來支持運動神經元的存活。因此,NRIP在維持神經肌肉接合處中所扮演的角色將是我們有興趣去探討的。神經肌肉接合處複合物的結構組成包含了乙醯膽鹼受體、受體相連突觸蛋白(rapsyn)和輔肌動蛋白異構體(α-actinin2, ACTN2)。在本研究中,我們用組織免疫螢光染色法來探討在正常小鼠中NRIP與神經肌肉接合處組成分的位置。結果顯示NRIP與乙醯膽鹼受體、受體相連突觸蛋白和輔肌動蛋白異構體共定位於神經肌肉接合處,這意味著NRIP也是神經肌肉接合處複合物的結構組成分之一,並且可能在維持神經肌肉接合處完整性中扮演著重要的角色。
另一方面,肌肉NRIP基因剔除小鼠的病徵與運動神經元疾病(motor neuron diseases, MNDs)類似,例如神經肌肉接合處異常、運動神經元退化和運動能力的缺陷,暗示著肌肉NRIP可以逆行調節運動神經元的存活。根據逆行死亡假說(dying back hypothesis),神經肌肉接合處的退化可能是導致運動功能逐漸惡化的原因,這說明了神經肌肉接合處可做為運動神經元疾病的治療標的。如前面所述,NRIP參與了神經肌肉接合處的形成,因此我們假設NRIP在運動神經元疾病中可以作為神經肌肉接合處的治療物。我們在肌肉NRIP基因剔除小鼠中,透過肌肉注射的方式來進行AAV-NRIP基因治療,以探討NRIP是否可以改善肌肉NRIP基因剔除小鼠的肌肉功能(包括肌肉氧化功能標誌物和肌肉力量)、運動神經元的存活(運動神經元數量)和神經肌肉接合處的功能〔包括神經肌肉接合處的面積和軸突神經支配/去神經支配的比例(axonal innervation/denervation)〕。值得注意的是,AAV-NRIP基因治療改善了肌肉NRIP基因剔除小鼠的慢肌凝蛋白(slow myosin)的表現、增加了神經肌肉接合處的面積與神經支配的比例,以及增強了運動神經元的存活。總結來說,AAV-NRIP可以挽救肌肉NRIP基因剔除小鼠的肌肉和運動功能。 另外,肌萎縮性脊髓側索硬化症(amyotrophic lateral sclerosis, ALS;運動神經元疾病的一種)目前尚無能完全治癒的藥物。ALS是一個運動神經元漸進性退化的疾病,並伴隨著神經肌肉接合處的異常。由於NRIP可以維持神經肌肉接合處的完整性,所以NRIP在ALS模式小鼠(hSODG93A mice)中的作用將是值得去發掘的,並且有機會能將NRIP發展成為ALS疾病的一個治療物。我們發現與正常小鼠相比之下,hSODG93A 小鼠的脊髓、腓腸肌和脛骨前肌中的NRIP蛋白表現量有顯著的下降,這意味著NRIP可能在hSODG93A 小鼠中扮演了角色。因此,我們未來將會對hSODG93A 小鼠進行AAV-NRIP基因治療來觀察是否可以改善ALS疾病的病徵。 除此之外,在我們先前的研究中有發現到隨著年紀的增長,NRIP蛋白表現量會隨之下降,並且運動能力也有顯著的變差。在本篇研究中,我們繼續透過觀察肌肉功能、運動神經元存活與神經肌肉接合處的功能來調查NRIP對老化過程的影響。結果顯示與正常的成鼠(16週齡)相比,老年小鼠(103週齡)的肌肉氧化功能異常並有運動能力的缺陷,還有運動神經元退化、神經肌肉接合處結構異常與軸突去神經支配的情況。這代表著肌肉NRIP的表現量下降可能是導致肌肉氧化能力異常、運動神經元缺失和神經肌肉接合處退化的原因之一。在未來我們將會研究AAV-NRIP基因治療是否能夠恢復老年小鼠的肌肉、運動神經元與神經肌肉接合處的功能。 | zh_TW |
dc.description.abstract | Nuclear receptor interaction protein (NRIP) is a Ca2+-dependent calmodulin-binding protein. NRIP can regulate muscle contraction through mediating mitochondrial activity and Ca2+ homeostasis. In previous study, we observed that NRIP global knockout (gKO) mice show muscle dystrophy and impaired motor performance. Moreover, muscle-specific NRIP conditional knockout (cKO) mice demonstrate that the deprivation of NRIP in muscle can cause motor neuron degeneration and neuromuscular junction (NMJ) abnormality. Besides, NRIP co-localizes with acetylcholine receptors (AChRs) at NMJ and acts as a trophic factor supporting spinal motor neuron via stabilization of NMJ. Therefore, the role of NRIP at NMJ maintenance would be interesting to investigate. The structural components of NMJ complex at muscle membrane include AChRs, rapsyn and α-actinin2 (ACTN2). Hence, in this study, we investigated the location of NRIP with NMJ components in WT mice by immunofluorescence assay. Results showed that NRIP co-localized with AChRs, rapsyn and ACTN2. This implied that NRIP is also a structural component of NMJ complex, and NRIP in muscle may play an important role in maintaining NMJ integrity.
On the other hand, muscle-specific NRIP cKO mice showed the phenotypes similar to motor neuron diseases (MNDs), such as NMJ abnormality, motor neuron degeneration and motor performance defects, implying that muscle NRIP can retrogradely regulate motor neuron survival. According to dying back hypothesis, NMJ degeneration may be the contributor to the progressive deterioration of motor function, suggesting that NMJ is a therapeutic target. As mentions, NRIP is involved in NMJ formation; therefore, we hypothesized that NRIP could be a therapeutic agent at NMJ in MNDs. We performed AAV-NRIP gene therapy in NRIP cKO mice through muscle injection to examine whether NRIP can improve muscle functions (including oxidative muscle markers and muscle strength), motor neuron survival (α-motor neurons number) and NMJ functions (including NMJ size and axonal innervation/denervation) in NRIP cKO mice. Notably, AAV-NRIP gene therapy through intramuscular injection improved slow myosin expression, increased NMJ size and innervation, and enhanced motor neuron survival in muscle-specific NRIP cKO mice. In sum, AAV-NRIP can rescue muscle and motor neuron functions in NRIP cKO mice. Additionally, there is not yet a cure treatment in amyotrophic lateral sclerosis (ALS; is one of the MNDs). ALS show progressive neurodegeneration and abnormalities at the NMJ. Due to NRIP functions for NMJ maintenance, the role of NRIP in hSODG93A mice (ALS mouse model) would be interesting to explore and it may be able to develop NRIP as a therapeutic agent for ALS. We found that the protein expression of NRIP in spinal cord, gastrocnemius (GAS) and tibialis anterior (TA) muscles were downregulated in hSODG93A mice compared with WT mice. This implied that NRIP might play a role in hSODG93A mice. Hence, we will perform AAV-NRIP therapy in hSODG93A mice in the future to investigate whether AAV-NRIP delivering can improve disease phenotypes of hSODG93A mice. Furthermore, we previously observed that the NRIP protein level of muscle tissues was decreased with advancing age along with the declination of motor functions. In this study, we continuously examined the effect of NRIP in aging through observing muscle functions, motor neuron survival and NMJ functions. Results showed muscle abnormality with reduction of muscle oxidative functions and motor function defects in aged mice (103-week-old) compared with adult wild type mice (16-week-old). Aged mice also displayed motor neuron degeneration, abnormal architecture of NMJ and axonal denervation. This implied that the reduction of NRIP in muscle may be the cause of muscle oxidative function abnormality, motor neuron loss and NMJ degeneration. In the future, we will examine whether AAV-NRIP can restore muscle, motor neuron and NMJ function in aged mice. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T04:31:22Z (GMT). No. of bitstreams: 1 ntu-107-R04445127-1.pdf: 2746984 bytes, checksum: 5f82bfdef39e6ee827c2695b793757f5 (MD5) Previous issue date: 2018 | en |
dc.description.tableofcontents | 口試委員審定書 I
誌謝 II 中文摘要 III Abstract VI Chapter 1 Introduction 1 1.1 Characteristics of nuclear receptor interaction protein (NRIP) 1 1.2 The mechanism of NRIP-regulated muscle contraction 3 1.3 The role of NRIP in neuron muscular junction formation 4 1.4 Characteristics of neuromuscular junction (NMJ) 5 1.5 Neuromuscular junction impairment in aging and myasthenia gravis (MG) 7 1.6 Neuromuscular junction disorder associated with motor neuron diseases 8 1.7 Characteristics of amyotrophic lateral sclerosis (ALS) 9 1.8 Gene therapy for motor neuron diseases 9 1.9 Aims of this study 10 Chapter 2 Materials and Methods 13 2.1 Study approval 13 2.2 Generation of muscle-specific NRIP knockout mice 13 2.3 ALS mouse model: hSODG93A mice 14 2.4 Immunohistochemistry of hindlimb muscles 15 2.5 COX and SDH staining 16 2.6 Mice spinal cord isolation and frozen section preparation 17 2.7 Immunofluorescence assay of spinal motor neurons 17 2.8 Immunofluorescence assay of neuromuscular junction (NMJ) 18 2.9 Immunofluorescence assay of NMJ components 20 2.10 Behavior test 21 2.11 AAV production 21 2.12 In vivo AAV injection 22 2.13 Western blots analysis 22 2.14 Statistical analysis 23 Chapter 3 Results 24 3.1 NRIP acts as a scaffold protein which is co-localized with neuromuscular junction (NMJ) complex. 24 3.2 Intramuscular NRIP gene transfer rescues abnormal phenotypes in muscle-specific NRIP conditional knockout (cKO) mice. 26 3.3 NRIP may play a role in hSODG93A mice. 30 3.4 Abnormal muscle oxidative functions in aged mice. 31 3.5 Degeneration of lumbar motor neurons in aged mice. 33 3.6 Abnormal architecture and function of neuromuscular junction in aged mice. 34 Chapter 4 Discussion 37 Chapter 5 Figures 45 Chapter 6 Supplementary 60 Chapter 7 Appendix 65 Chapter 8 References 68 | |
dc.language.iso | en | |
dc.title | 肌肉NRIP對於神經肌肉接合處的維持之重要性探討 | zh_TW |
dc.title | Muscle-derived NRIP is essential for neuromuscular junction maintenance | en |
dc.type | Thesis | |
dc.date.schoolyear | 106-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 陳佑宗(You-Tzung Chen),蔡力凱(Li-Kai Tsai) | |
dc.subject.keyword | 核受體交互作用蛋白,神經肌肉接合處,基因治療,肌萎縮性脊髓側索硬化症,老化, | zh_TW |
dc.subject.keyword | NRIP,neuromuscular junction,gene therapy,amyotrophic lateral sclerosis,aging, | en |
dc.relation.page | 77 | |
dc.identifier.doi | 10.6342/NTU201802090 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2018-08-13 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 微生物學研究所 | zh_TW |
顯示於系所單位: | 微生物學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-107-1.pdf 目前未授權公開取用 | 2.68 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。